MS
Mark Sabag sold $1.9M of TEVA stock
Mark Sabag, See "Remarks" of Teva Pharmaceutical Industries Ltd (TEVA), sold 46,000 shares of TEVA stock worth $1.9M, per an SEC Form 4 filed Nov 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 5, 2026, 1 day before it was made public.
TEVA has moved +0.0% since the trade date, from $41.74 to $41.74 (Nov 5, 2026 close).
- Traded
- Nov 5, 2026
- Disclosed
- Nov 6, 2026
- Filing delay
- 1 day
- Price since
- +0.0%
- Role
- See "Remarks"
- Source
- SEC Form 4